The intensity dependence of auditory ERP components in unmedicated patients with major depression and healthy controls. An analysis of group differences

Journal of Affective Disorders

Volumn 103, Issue 1-3, 2007, Pages 139-145

  Linka, Thomas ^a,c   Sartory, Gudrun ^b   Bender, Stefan ^a   Gastpar, Markus ^a   Müller, Bernhard W ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY OF WUPPERTAL   (Germany)

^c VINCENT VAN GOGH INSTITUTE FOR PSYCHIATRY   (Netherlands)

Author keywords

Antidepressants; ERP; Major depression; N1; N1 P2; SSRI

Indexed keywords

ANTIDEPRESSANT AGENT;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EVENT RELATED POTENTIAL; EVOKED AUDITORY RESPONSE; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; NEUROTRANSMISSION; PRIORITY JOURNAL; RATING SCALE;

ACOUSTIC STIMULATION; ADULT; CEREBRAL CORTEX; DEPRESSIVE DISORDER, MAJOR; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; LOUDNESS PERCEPTION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OVUM; REFERENCE VALUES; SEROTONIN; SOUND SPECTROGRAPHY;

EID: 34548843892     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2007.01.018     Document Type: Article

References (35)

1. Beauducel A., Debener S., Brocke B., and Kayser J. On the reliability of augmenting/reducing. Peak amplitudes and principal component analysis of auditory evoked potentials. J. Psychophysiol. 14 (2000) 226-240
2. Beck A.T., Ward C.H., Mendelson M., Mock J., and Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry 4 (1961) 561-571
3. Brocke B., Beauducel A., John R., Debener S., and Heilemann H. Sensation seeking and affective disorders: characteristics in the intensity dependence of acoustic evoked potentials. Neuropsychobiology 41 (2000) 24-30
4. Buchsbaum M., and Silverman J. Stimulus intensity control and the cortical evoked response. Psychosom. Med. 30 (1968) 12-22
5. Croft R.J., Klugman A., Baldeweg T., and Gruzelier J.H. Electrophysiological evidence of serotonergic impairment in long-term MDMA ("ecstasy") users. Am. J. Psychiatry 158 (2001) 1687-1692
6. Gallinat J., Bottlender R., Juckel G., Munke-Puchner A., Stotz G., Kuss H.J., Mavrogiorgou P., and Hegerl U. The loudness dependency of the auditory evoked N1/P2-component as a predictor of the acute SSRI response in depression. Psychopharmacology (Berl) 148 (2000) 404-411
7. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry (1960) 56-62
8. Hamilton M. HAMA, Hamilton Anxiety Scale. In: Guy W. (Ed). ECDEU Assessment manual for psychopharmacology (1976), US Department of Health and Human Services, Rockville, MD 194-198
9. Hegerl U., Bottlender R., Gallinat J., Kuss H.J., Ackenheil M., and Moller H.J. The serotonin syndrome scale: first results on validity. Eur. Arch. Psychiatry Clin. Neurosci. 248 (1998) 96-103
10. Hegerl U., Gallinat J., and Juckel G. Event-related potentials. Do they reflect central serotonergic neurotransmission and do they predict clinical response to serotonin agonists?. J. Affect. Disord. 62 (2001) 93-100
11. Hensch T., Wargelius H.L., Herold U., Lesch K.P., Oreland L., and Brocke B. Further evidence for an association of 5-HTTLPR with intensity dependence of auditory-evoked potentials. Neuropsychopharmacology (2006)
12. Juckel G., Hegerl U., Molnar M., Csepe V., and Karmos G. Auditory evoked potentials reflect serotonergic neuronal activity-a study in behaving cats administered drugs acting on 5-HT1A autoreceptors in the dorsal raphe nucleus. Neuropsychopharmacology 21 (1999) 710-716
13. Juckel G., Gallinat J., Riedel M., Sokullu S., Schulz C., Moller H.J., Muller N., and Hegerl U. Serotonergic dysfunction in schizophrenia assessed by the loudness dependence measure of primary auditory cortex evoked activity. Schizophr. Res. 64 (2003) 115-124
14. Lee T.W., Yu Y.W., Chen T.J., and Tsai S.J. Loudness dependence of the auditory evoked potential and response to antidepressants in Chinese patients with major depression. J. Psychiatry Neurosci. 30 (2005) 202-205
15. Linka T., Müller B.W., Bender S., and Sartory G. The intensity dependence of the auditory evoked N1 component as a predictor of response to Citalopram treatment in patients with major depression. Neurosci. Lett. 367 (2004) 375-378
16. Linka T., Müller B.W., Bender S., Sartory G., and Gastpar M. The intensity dependence of auditory evoked ERP components predicts responsiveness to reboxetine treatment in major depression. Pharmacopsychiatry 38 (2005) 139-143
17. Mulert C., Jager L., Pogarell O., Bussfeld P., Schmitt R., Juckel G., and Hegerl U. Simultaneous ERP and event-related fMRI: focus on the time course of brain activity in target detection. Methods Find. Exp. Clin. Pharmacol. 24 Suppl D (2002) 17-20
18. (NIMH), N.I.o.M.H., 1976. CGI. Clinical global impressions. In: Bonato, R. (Ed.), Manual for the EDCEU assessment battery, 2nd ed. NIMH, Chevy Chase.
19. Norra C., Mrazek M., Tuchtenhagen F., Gobbele R., Buchner H., Sass H., and Herpertz S.C. Enhanced intensity dependence as a marker of low serotonergic neurotransmission in borderline personality disorder. J. Psychiatr. Res. 37 (2003) 23-33
20. Owens M.J. Selectivity of antidepressants: from the monoamine hypothesis of depression to the SSRI revolution and beyond. J. Clin. Psychiatry (2004) 5-10
21. Paige S.R., Fitzpatrick D.F., Kline J.P., Balogh S.E., and Hendricks S.E. Event-related potential amplitude/intensity slopes predict response to antidepressants. Neuropsychobiology 30 (1994) 197-201
22. Proietti-Cecchini A., Afra J., and Schoenen J. Intensity dependence of the cortical auditory evoked potentials as a surrogate marker of central nervous system serotonin transmission in man: demonstration of a central effect for the 5HT1B/1D agonist zolmitriptan (311C90, Zomig). Cephalalgia (1997) 849-854 (discussion 799)
23. Proietti-Cecchini A., Afra J., and Schoenen J. Intensity dependence of the cortical auditory evoked potentials as a surrogate marker of central nervous system serotonin transmission in man: demonstration of a central effect for the 5HT1B/1D agonist zolmitriptan (311C90, Zomig). Cephalalgia 17 (1997) 849-854 (discussion 799)
24. Riedel W.J., Klaassen T., Griez E., Honig A., Menheere P.P., and van Praag H.M. Dissociable hormonal, cognitive and mood responses to neuroendocrine challenge: evidence for receptor-specific serotonergic dysregulation in depressed mood. Neuropsychopharmacology 26 (2002) 358-367
25. Sandor P.S., Roon K.I., Ferrari M.D., van Dijk J.G., and Schoenen J. Repeatability of the intensity dependence of cortical auditory evoked potentials in the assessment of cortical information processing. Cephalalgia 19 (1999) 873-879
26. Semlitsch H.V., Anderer P., Schuster P., and Presslich O. A solution for reliable and valid reduction of ocular artifacts, applied to the P300 ERP. Psychophysiology (1986) 695-703
27. Senkowski D., Linden M., Zubragel D., Bar T., and Gallinat J. Evidence for disturbed cortical signal processing and altered serotonergic neurotransmission in generalized anxiety disorder. Biol. Psychiatry 53 (2003) 304-314
28. Spielberger C.D. Manual for the State-Trait-Anxiety Inventory (1970), Consulting Psychologist Press, Palo Alto
29. Strobel A., Debener S., Schmidt D., Hunnerkopf R., Lesch K.P., and Brocke B. Allelic variation in serotonin transporter function associated with the intensity dependence of the auditory evoked potential. Am. J. Med. Genet. 118B (2003) 41-47
30. Tuchtenhagen F., Daumann J., Norra C., Gobbele R., Becker S., Pelz S., Sass H., Buchner H., and Gouzoulis-Mayfrank E. High intensity dependence of auditory evoked dipole source activity indicates decreased serotonergic activity in abstinent ecstasy (MDMA) users. Neuropsychopharmacology 22 (2000) 608-617
31. von Knorring L., and Perris C. Biochemistry of the augmenting-reducing response in visual evoked potentials. Neuropsychobiology (1981) 1-8
32. Wang W., Timsit-Berthier M., and Schoenen J. Intensity dependence of auditory evoked potentials is pronounced in migraine: an indication of cortical potentiation and low serotonergic neurotransmission?. Neurology (1996) 1404-1409
33. Willeit M., Praschak-Rieder N., Neumeister A., Zill P., Leisch F., Stastny J., Hilger E., Thierry N., Konstantinidis A., Winkler D., Fuchs K., Sieghart W., Aschauer H., Ackenheil M., Bondy B., and Kasper S. A polymorphism (5-HTTLPR) in the serotonin transporter promoter gene is associated with DSM-IV depression subtypes in seasonal affective disorder. Mol. Psychiatry 8 (2003) 942-946
34. Yoshida K., Takahashi H., Higuchi H., Kamata M., Ito K., Sato K., Naito S., Shimizu T., Itoh K., Inoue K., Suzuki T., and Nemeroff C.B. Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms. Am. J. Psychiatry 161 (2004) 1575-1580
35. Zuckerman M., Murtaugh T., and Siegel J. Sensation seeking and cortical augmenting-reducing. Psychophysiology 11 (1974) 535-542